BiotechTube

Placebo + AVI-6002

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
30
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ebola Hemorrhagic Fever

Conditions

Ebola Hemorrhagic Fever

Trial Timeline

May 1, 2010 โ†’ Nov 1, 2011

NCT ID
NCT01353027

About Placebo + AVI-6002

Placebo + AVI-6002 is a phase 1 stage product being developed by United Therapeutics for Ebola Hemorrhagic Fever. The current trial status is completed. This product is registered under clinical trial identifier NCT01353027. Target conditions include Ebola Hemorrhagic Fever.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01353027Phase 1Completed

Competing Products

20 competing products in Ebola Hemorrhagic Fever

See all competitors
ProductCompanyStageHype Score
Ad26.ZEBOV vaccineJohnson & JohnsonPhase 2
52
rVSVฮ”G-ZEBOV-GP, V920 + Chikenpox or Varicella vaccine (VARILRIX)MerckPhase 1/2
41
V920 VaccineMerckPhase 1
33
Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSVโˆ†G-ZEBOV-GP)MerckPhase 2
52
rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)MerckApproved
85
V920 (rVSVฮ”G-ZEBOV-GP) Ebola Virus VaccineMerckPhase 2
52
V920MerckPhase 1
33
V920 Consistency Lot A + V920 Consistency Lot B + V920 Consistency Lot C + V920 High-dose Lot + Placebo to V920MerckPhase 3
77
BioNTech - Pfizer COVID-19 vaccine + 1mL saline solution + rVSVโˆ†G-ZEBOV-GPMerckApproved
85
V920MerckPhase 1
33
GS-5734Gilead SciencesPhase 2
51
REGN3470-3471-3479Regeneron PharmaceuticalsPre-clinical
22
Ervebo + InmazebRegeneron PharmaceuticalsPhase 2
51
AVI-7537United TherapeuticsPhase 1
30
Ad26.ZEBOV + MVA-BN-FiloBavarian NordicPhase 3
74
CMX001Jazz PharmaceuticalsPhase 2
49
BrincidofovirJazz PharmaceuticalsPhase 2
49
cAd3-Marburg + cAd3-EBO-SICON plc.Phase 1
30
Base Dose EBOV GP Vaccine + 2x Base Dose EBOV GP Vaccine + 4x Base Dose EBOV GP Vaccine + 8x Base Dose EBOV GP Vaccine + Placebo + Matrix-M AdjuvantNovavaxPhase 1
28
TKM-100802 for Injection + PlaceboArbutus BiopharmaPhase 1
28

Other Products from United Therapeutics

TreprostinilApproved
82
RemodulinApproved
82
Remodulin (treprostinil sodium)Approved
82
Intravenous TreprostinilApproved
82
Intravenous/Subcutaneous Treprostinil; Oral TreprostinilApproved
82